OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

On and upwards

This outfit always has Announcements . . . but nowhere do we see any profits.
Hence it is stuck at 2p
That's really poor, and is a reflection on the abilities of Management.
EDIT (23April2014)- Well done Oakapples - you've done better than any LT investor, +congrats!.
EDIT (2June2014)-Don't expect any gains awhile as the enormous Rights Issue works through.....Disappointed moi? Surely not...
EDIT ( 11June2014)-Well agin my better judgement I took up the Rights at 2p as there is a cash-generation prospect: 1) Deal with Novatis made £6m under 1yr. and likely to rise with fresh investment in Plant. 2) Ocular progress isn't as bad as I thought.... and they are active in Parkinsons too. 3) It's a small additional inv. so might as well. 4) They get the money - but I may live to regret it ! ! ! . . . . DYOR. (Offer Closed yesterday)

Hangon - Hangon i just made £ 12.74

Moving up each day -any views?

It's a gamble... if you think their platform will come good then Hold-on . . . but many prefer to wait and jump-on when the train is leaving for somewhere . . . At last they seem to be focussed on profits so maybe the Directors are discarding their (research) white coats and soon join the Top Table in Pharma Profits - the next 2-years will see if that Is, or ain't the case . . . . no-one really knows, esp. as it also depends on other Research piping them to their post.

However at 2p almost any good News should produce a big rise - it's just far too low for a £100m TO business (er, soon I wish!). Hang on in Oakapples that £12 could become £100.

Thanks for the "Hold On" - "Hangon On" !! Now worth quite a lot more than I was losing!

Chief Development Officer appointed - is there some "development" pending I ask myself.
Have a large interest in this one.

Up up and Away again to-day.

Well, maybe slowly as their business strategy starts to look sound. Up to now it's been Hope dusted with a little Hype . . . . now with the Manufacturing deal and potential for expansion, just maybe there is something to look forward to.
However, this still depends on what's in it for new investors . . . so sometime soon there needs to be a sniff of a Dividend and with all those shares in circulation I don't see that being more than a nominal % - so nothing to get too excited about.
EDIT(26Sept14) ....... above some emphasis altered...........
The recent Rights was a blow for LT shareholders and a good price to get it away . . . so the recent rise is not surprising. However, when it reaches 50p - then many LT holders will know they did back a good'un. The problem is that investors "now" probably will jump-ship before that happens....
EDIT (14 Oct2014) - Moved up nearly 5% - to 4p.......(5Dec14)-now above 5p.
EDIT (mid-Jan2015 )- touched 7p...& Looks to be Motoring gently; I guess Mkt thinks the risks are down - New premises, an Income, Etc. Still needs to reach 40p - but when?
EDIT (27 JAn2015)- well if it really hit 10p before the fall to 6p I'd be surprised (as any Sells would destroy the spike - and did!).
Can't see why the spike occurred at all . . . I read little "Super-Good" News, but that's Markets ( -or MM's ? ). Maybe in the Spring we'll read some News.

Nice steady rise practically daily. Been in here for 14 years and now just in profit.

Is anyone out there - you are missing out.

MMs seem to be holding SP @5.5p.

Several large OXB buys not registering - either as buy or sell. Several hours elapse before new buys are shown.

Suspect MMs short of stock as OXB is tightly held share and has been for many loyal supporters who have topped up over many years. With the new manufacturing facility and big player support, 'Singer' have uprated OXB to 6.9p.

RNS states that OXB is now financially stable for the foreseeable future, and new revenues coming online H1 2015. With a PE to be determined then.

I am back in and will top up on troughs.

DYOR

HAb

Still going well - a new chart would look nice - well covering the losses of my oilers

IMO ... this will continue to push upwards, - with a few troughs caused by nervous punters. Am expecting the new re-rating to be @12p. After this OXB need to produce an RNS to present manufacturing predictions and supporting financials etc, before it can continue towards @30p.

After consolidation @30p long term will be primarily driven by revenues and successful drug pipeline. Perhaps beyond 50p as the drug market and economy grows.

Will continue to recycle shares on peaks and troughs up to the above.

DYOR

HAb

Cracking chart.

Up another 10% today.

And climbing - did push 10p - commenced ownership of OXB 14 years ago and have added to quite regularly . Thank you for the chart mitzy - not one of my qualities but I do have patience !! Get in there.

I read this is now a "buy" by IC - but I wonder what they missed when OXB was 2p - giving reckless investors a thumping 6x reward?
Of course there is "risk" and some of the treatments will be less than successful ( as in the past!), but it needs only one good one and we're away to nudge £1 ( some hope?), as they seem to be well-funded with regular income avoiding that other issue for small-Bios ( Dilution !).
I wonder if Oakapples can work out just how much L-T dilution has cost him - (like me), since those early days? . . . . I'd be surprised if my Av. buy-price isn't about 50p.
Ooo-er!

EDIT (30April2015)- I missed Director sale of 85million Jan 2015. - at 5p....how bad was that? - wait a few months and he could have seen double...11p today.
EDIT (27May2015)- I see a Dir. buying 100,000 at 10p - that's £10G-worth, a little below my "Notice-level" of £50k - but good, even so.
EDIT (17Dec2015)- New Chairman Lorenzo- appointed . . . has pharma industry experience with big players.... I suspect this is the NEWS we've need . . along with an Income stream from 3rd party Manufacture for Novatis.... time will tell, but I can see sp rising as he gets to grips with their future . . . . well...Hope, eh?
Loreanz was the cypher code use in WWII along with Enigma.

Into a new year 2016 for OXB, with manufacturing ramping up and new facility starting to earn revenues. Bit of change around in Exec team.

Perhaps OXB is streamlining to make its balance sheet more attractive and focus on manufacturing and delivery to Novartis / markets. Will become a more attractive takeover target as OXB starts to register on large Institutions radar. Once steady delivery of drug pipeline established, expect small step into dividends. Once this happens expect serious SP rerating.

Am Sticking by my long-term predictions of SP @30p - 40p by this time next year 2017.

DYOR
HAb